[8-K] SunLink Health Systems, Inc Reports Material Event

Rhea-AI Filing Summary

SunLink Health Systems, Inc. (SSY) filed a Form 8-K to disclose an Amendment to the Amended & Restated Agreement and Plan of Merger with Regional Health Properties, Inc. The amendment, signed 22 June 2025, extends the Merger Agreement’s “Termination Date” from 30 June 2025 to 11 August 2025 (5:00 p.m. ET) and makes a minor clean-up revision.

The extension was needed because neither SunLink nor Regional has yet received their respective shareholder approvals. Both boards determined that the approvals could not be obtained by the original deadline and therefore agreed to push back the outside date. All other material terms of the Merger Agreement remain unchanged. Either party may still terminate the deal if the merger is not consummated by the new deadline.

No financial statements, earnings metrics, or revised merger economics were included in this filing. Exhibit 2.1 contains the full text of the amendment, and an Inline XBRL cover page (Exhibit 104) was provided.

• The filing reiterates that the joint proxy statement/prospectus will be filed on Form S-4 and urges investors to read it once available.
• The company restates customary “no offer or solicitation” language and an extensive list of forward-looking risk factors.

Investor takeaway: The merger remains pending but now faces at least a six-week delay, highlighting continued execution risk tied to securing shareholder and regulatory approvals.

Positive

• Parties reaffirm commitment to the Regional–SunLink merger by mutually extending the outside date, signalling strategic intent to close the deal.

Negative

• Shareholder approvals still outstanding, indicating potential dissent and adding execution risk.
• Deadline extension implies prior timeline was unachievable, creating further uncertainty and possible delay-related costs.

Insights

M&A Specialist

TL;DR: Deadline moved to 11 Aug 2025; shows commitment but highlights lingering approval risk—neutral overall.

The extension keeps the transaction alive without changing consideration or closing conditions, signalling both parties still believe in strategic merits. However, failure to secure shareholder votes by the original cut-off reveals traction issues and adds time-related uncertainty. The outside date is now only six weeks away, leaving limited buffer for regulatory review and proxy distribution. From a deal-arbitrage standpoint, probability of completion is intact yet modestly reduced due to lingering dissent risk. No financial sweeteners accompany the delay, so the market should treat this as procedurally neutral.

Healthcare Services Portfolio Manager

TL;DR: Operational impact minimal today; delay underscores execution risk for SSY equity—neutral to slightly negative.

SunLink continues to operate small rural hospitals and pharmacies; cash flow pressure makes merger consummation strategically important. Pushing back the deadline suggests management still envisions synergy benefits, yet inability to line up votes may hint at shareholder skepticism. Absent fresh financials, the filing provides no clarity on integration planning or expected cost savings. For investors, thesis hinges on the merger closing; slippage compresses timeline and could elevate financing costs if macro conditions shift.

0000096793false00000967932025-06-222025-06-22

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

	Date of report (Date of earliest event reported): June 22, 2025
	SunLink Health Systems, Inc.
	(Exact Name of Registrant as Specified in its Charter)
Georgia	001-12607	31-0621189
(State or Other Jurisdiction of	(Commission	(I.R.S. Employer
Incorporation)	File Number)	Identification No.)
	900 Circle 75 Parkway
	Suite 690
	Atlanta, Georgia 30339
	(Address of Principal Executive Offices, and Zip Code)
	(770) 933-7000
	(Registrant’s telephone number, including area code)

Not applicable.

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☒	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Shares without par value	SSY	NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry Into a Material Definitive Agreement

As previously disclosed, on April 14, 2025, SunLink Health Systems, Inc., a Georgia corporation (“SunLink”), and Regional Health Properties, Inc., a Georgia corporation (“Regional”), entered into an Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”) pursuant to which SunLink will merge with and into Regional (the “Merger”), with Regional surviving the Merger as the surviving corporation. The Merger Agreement provides that it may be terminated if the effective time of the Merger shall not have occurred by 5:00 p.m., Eastern time, on June 30, 2025 (“Termination Date”).

On June 22, 2025, SunLink and Regional entered into an Amendment to Amended and Restated Agreement and Plan of Merger (the “Amendment”) pursuant to which Regional and SunLink each agreed to extend the “Termination Date” until 5:00 p.m., Eastern time, on August 11, 2025 and make a clarifying clean-up change. SunLink and Regional acknowledge in the Amendment that the Regional Shareholder Approval (as defined in the Merger Agreement, as amended by the Amendment) and the SunLink Shareholder Approval (as defined in the Merger Agreement, as amended by the Amendment) have not been obtained and that Regional and SunLink have reasonably determined that such outstanding approvals will not be obtained by 5:00 p.m., Eastern time, on June 30, 2025. In light of these outstanding approvals, Regional and SunLink determined to approve the Amendment. As amended, the Merger Agreement may be terminated by each of Regional and SunLink under certain circumstances, including if the Merger is not consummated by 5:00 p.m., Eastern time, on August 11, 2025.

The foregoing description of the Amendment is qualified in its entirety by reference to the Amendment, a copy of which is filed as Exhibit 2.1 hereto and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit
Number						Description
2.1						Amendment to Amended and Restated Agreement and Plan of Merger, dated as of June 22, 2025, by and between Regional Health Properties, Inc. and SunLink Health Systems, Inc.
104						Cover page in Inline XBRL format

* * *

NO OFFER OR SOLICITATION

Communications in this Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any proxy vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended (the “Securities Act”).

ADDITIONAL INFORMATION

The proposed merger will be submitted to both the SunLink and Regional shareholders for their consideration. In connection with the proposed merger, Regional will file a Registration Statement on Form S-4 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (the “SEC”) that will include a joint proxy statement/prospectus for SunLink and Regional and other relevant documents concerning the proposed merger.

INVESTORS ARE URGED TO READ THE REGISTRATION STATEMENT AND THE CORRESPONDING JOINT PROXY STATEMENT/PROSPECTUS REGARDING THE PROPOSED MERGER WHEN IT BECOMES AVAILABLE, AS WELL AS ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, TOGETHER WITH ALL AMENDMENTS AND SUPPLEMENTS TO THOSE DOCUMENTS, AS THEY WILL CONTAIN IMPORTANT INFORMATION.

1

You will be able to obtain a copy of the joint proxy statement/prospectus once filed, as well as other filings containing information about SunLink and Regional, without charge, at the SEC’s website (http://www.sec.gov) or by accessing SunLink’s website (http://www.sunlinkhealth.com) under the tab “Investors” or by accessing Regional’s website (http://www.regionalhealthproperties.com) under the tab “Investor Relations.” Copies of the joint proxy statement/prospectus can also be obtained, without charge, by directing a request to Investor Relations, SunLink Health Systems, Inc., 900 Circle 75 Parkway, Suite 690, Atlanta, Georgia, 30339, telephone 770-933-7004 or to Investor Relations, Regional Health Properties, Inc., 1050 Crown Pointe Parkway, Suite 720, Atlanta, Georgia, 30338, telephone 678-869-5116.

SunLink and Regional and certain of their directors and executive officers may be deemed to be participants in the solicitation of proxies from the shareholders of SunLink and Regional in connection with the proposed merger. Information about the directors and executive officers of SunLink is set forth in Part III of SunLink’s Amendment No. 1 to Annual Report on Form 10-K/A for the fiscal year ended June 30, 2024, which information may be updated by SunLink from time to time in subsequent filings with the SEC. Information about the directors and executive officers of Regional is set forth in Part III of Regional’s Annual Report on Form 10-K for the year ended December 31, 2024, which information may be updated by Regional from time to time in subsequent filings with the SEC. Additional information about the interests of those participants and other persons who may be deemed participants in the transaction may also be obtained by reading the joint proxy statement/prospectus relating to the proposed merger when it becomes available. Free copies of this document may be obtained as described above.

Cautionary Note Regarding Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements can often, but not always, be identified by the use of words like “believe”, “continue”, “pattern”, “estimate”, “project”, “intend”, “anticipate”, “expect” and similar expressions or future or conditional verbs such as “will”, “would”, “should”, “could”, “might”, “can”, “may”, or similar expressions. These forward-looking statements include, but are not limited to, statements relating to the expected timing and benefits of the proposed merger between Regional and SunLink, including statements of Regional’s goals, intentions and expectations; statements regarding Regional’s business plan and growth strategies; and the ability of Regional to meet the continued listing requirements of the NYSE American and to maintain the listing of securities thereon.

These forward-looking statements are subject to significant risks, assumptions and uncertainties that may cause results to differ materially from those set forth in forward-looking statements, including, among other things:

•the risk that the businesses of Regional and SunLink will not be integrated successfully or such integration may be more difficult, time-consuming or costly than expected;

•expected revenue synergies and cost savings from the merger may not be fully realized or realized within the expected time frame;

•revenues following the merger may be lower than expected;

•customer, vendor and employee relationships and business operations may be disrupted by the merger;

•the ability to obtain required regulatory approvals or the approvals SunLink’s or Regional’s shareholders, and the ability to complete the merger on the expected timeframe;

•the costs and effects of litigation and the possible unexpected or adverse outcomes of such litigation;

•the ability of Regional and SunLink to meet the continued listing requirements or rules of the NYSE American LLC or the OTCQB, as applicable, and to maintain the listing or trading, as applicable, of securities thereon;

•possible changes in economic and business conditions;

•the impacts of epidemics, pandemics or other infectious disease outbreaks;

2

•the existence or exacerbation of general geopolitical instability and uncertainty;

•possible changes in monetary and fiscal policies, and laws and regulations;

•competitive factors in the healthcare industry;

•Regional’s dependence on the operating success of its operators;

•the amount of, and Regional’s ability to service, its indebtedness;

•covenants in Regional’s debt agreements that may restrict its ability to make investments, incur additional indebtedness and refinance indebtedness on favorable terms;

•the effect of increasing healthcare regulation and enforcement on Regional’s operators and the dependence of Regional’s operators on reimbursement from governmental and other third-party payors;

•the relatively illiquid nature of real estate investments;

•the impact of litigation and rising insurance costs on the business of Regional’s operators;

•the effect of Regional’s operators declaring bankruptcy, becoming insolvent or failing to pay rent as due;

•the ability of any of Regional’s operators in bankruptcy to reject unexpired lease obligations and to impede its ability to collect unpaid rent or interest during the pendency of a bankruptcy proceeding and retain security deposits for the debtor’s obligations;

•Regional’s ability to find replacement operators and the impact of unforeseen costs in acquiring new properties; and

•other risks and factors identified in (i) SunLink’s cautionary language included under the headings “Forward-Looking Statements” and “Risk Factors” in SunLink’s Annual Report on Form 10-K for the year ended June 30, 2024, and other documents subsequently filed by SunLink with the SEC and (ii) Regional’s cautionary language included under the headings “Statement Regarding Forward-Looking Statements” and “Risk Factors” in Regional’s Annual Report on Form 10-K for the year ended December 31, 2024, and other documents subsequently filed by Regional with the SEC.

Neither SunLink nor Regional undertake any obligation to update any forward-looking statement, whether written or oral, relating to the matters discussed in this Current Report on Form 8-K. In addition, SunLink’s and Regional’s past results of operations do not necessarily indicate either of their anticipated future results, whether the merger is effectuated or not.

3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	SUNLINK HEALTH SYSTEMS, INC.
Date: June 23, 2025	/s/ Mark J. Stockslager
	Mark J. Stockslager
	Chief Financial Officer

4

FAQ

Why did SunLink (SSY) extend the merger termination date?

Because neither SunLink nor Regional had secured shareholder approvals by 30 June 2025, necessitating additional time.

What is the new outside date for the SunLink-Regional merger to close?

The merger must now close by 5:00 p.m. ET on 11 August 2025 or either party may terminate.

Did the amendment change the merger consideration or other key terms?

No. The filing states only a deadline extension and a minor clean-up edit; all other terms remain the same.

Are financial statements or updated synergy estimates included?

No financial statements, earnings metrics, or revised synergy projections were provided in this Form 8-K.

What are the next steps for SunLink shareholders regarding the merger?

Shareholders should review the forthcoming Form S-4 joint proxy statement/prospectus and vote when solicitations begin.